DUBLIN, December 4 (HSMN NewsFeed) — Azur Pharma Limited ("Azur") today announced that it has entered into a definitive agreement with BioSante Pharmaceuticals, Inc ("BioSante")(Nasdaq: BPAX ) to acquire U.S. rights to Elestrin(TM). …
Biopharmaceuticals, Acquisitions
Azur Pharma, BioSante Pharmaceuticals, Elestrin, estradiol

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc [nasdaq: BPAX], to Acquire U.S. Rights to Elestrin (TM)”
Leave a Comment